The Uterine Manipulation Devices Market was valued at US$ 297.7 Million in 2022, and now it is expected to grow with a CAGR of 6.1% from 2023 to 2033. Increased acceptance of minimally invasive or non-invasive procedures, as well as technical improvements, are among the primary drivers propelling the industry in recent years. The market accounted for an absolute dollar opportunity of nearly US$ 255.2 Million from 2023 to 2033.
| Attribute | Details |
|---|---|
| Global Uterine Manipulation Devices Market (2023) | US$ 315 Million |
| Global Uterine Manipulation Devices Market (2033) | US$ 570.3 Million |
| Global Uterine Manipulation Devices Market CAGR (2023 to 2033) | 6.1% |
| USA Uterine Manipulation Devices Market CAGR (2023 to 2033) | 6.2% |
| Key Companies Profiled |
|
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
As per the Uterine Manipulation Devices Market industry research by Future Market Insights - a market research and competitive intelligence provider, historically, from 2018 to 2022, the market value of the Uterine Manipulation Devices increased at around 5.4% CAGR. The market is projected to grow at a CAGR of 6.1% over the coming ten years.
The rising frequency of various gynecological problems, as well as the rising use of uterine manipulation devices due to their ease of use and comfort, are likely to fuel market expansion throughout the forecast period. UF tumors become more common as women become older, with over 30% of women between the ages of 40 and 60 suffering from them.
Women in their late 40s and early 50s are most likely to acquire UF tumors, while they can develop at any age. Because of the growing number of women with UF tumors, the number of hysterectomy procedures has increased, resulting in a substantial need for uterine manipulation devices.
Principal Consultant
Due to the lower risk involved with these procedures, minimally invasive and non-invasive surgeries are becoming increasingly popular. Smaller incisions reduce postoperative pain and speed healing owing to which these treatments are so widely used. Laparoscopic or robotic-assisted hysterectomy, for example, is a less intrusive procedure for removing the uterus.
A small incision in the lower belly is created, and a miniature camera and small, specialized equipment are inserted and utilized to remove the object. Minimally invasive techniques, on the other hand, have a lower risk of blood loss and infection than open surgery. As a result, a rise in patient demand for non-invasive or minimally invasive therapy, as well as the benefits provided by these procedures, is likely to propel the market at a rapid pace over the forecast period.
North America is expected to account for a significant proportion of the uterine manipulation devices revenue. This is due to an increase in the number of gynecology-related surgical procedures and hospital visits, as well as the availability of well-established healthcare infrastructure, favorable reimbursement policies, and supportive legislative reforms in the healthcare sector. Based on statistics from CMS, healthcare spending in the United States reached US$ 3.8 Trillion, climbing by 4.6% in 2019. It accounted for 17.7% of the country’s GDP. The national health spending is predicted to expand at a 5.4% annual pace, reaching US$ 6.2 trillion by 2028.
During the projected period, the market in Asia Pacific is expected to grow at a significant pace. The regional market is predicted to develop significantly due to the presence of a huge patient pool and the growing need for technologically improved and cost-effective healthcare solutions.
A rise in the number of clinical trials and significant research and development investments by global market players to penetrate untapped markets in the country as a result of low-cost services is high-impact rendering market drivers. Furthermore, the market expansion is aided by an increase in the number of hospitalizations and significant innovations in developing nations' clinical development frameworks.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The market in the USA is expected to grow at a CAGR of 6.2% from 2023 to 2033, to reach a valuation of US$ 180.6 Million. During the forecast period, the market is projected to witness an absolute dollar opportunity of US$ 81.8 Million.
The market in the United Kingdom is expected to reach a valuation of US$ 25.1 Million by 2033. Growing with a CAGR of 6.2% in the forecast period, the market in the country is projected to garner an absolute dollar opportunity of around US$ 11.4 Million.
In Japan, the market is expected to grow at a CAGR of 5.8% from 2023 to 2033, reaching around US$ 21.3 Million by 2033. The market in the country is expected to gross an absolute dollar opportunity of US$ 9.2 Million during the forecast period.
The market in South Korea is expected to reach a valuation of around US$ 11.6 Million by 2033, growing at a CAGR of 5.2% from 2023 to 2033. The market in the country is expected to witness an absolute dollar opportunity of around US$ 4.7 Million.
With a market share of over 55% in 2022, the uterine manipulation equipment market through hospitals is expected to garner significant demand. Its growth is mostly due to an increase in the number of patients suffering from various gynecological problems, as well as the number of surgical procedures performed as a result.
Hospitals provide greater patient care and reimburse for specific operations, which is contributing significantly to revenue growth. In addition, hospitals are becoming more technologically advanced. In order to give better care, hospitals are increasingly using technologically advanced technology. These devices not only make treatment procedures easier, but they also deliver better, faster, and more precise results.
The growing number of uterus surgeries, increased attention on woman health hygiene, public awareness of various new advanced technologies, and growing concerns about health problems and the need to cure them are all projected to boost the global market for uterine manipulator devices.
The key players in the global Uterine Manipulation Devices market are Conkin Surgical Instruments Ltd, Johnson and Johnson, CooperSurgical Inc, B. Braun Medical Ltd, and KARL STORZ GmbH & Co. KG.
The market is valued at US$ 315 million in 2023.
Conkin Surgical Instruments Ltd, Johnson and Johnson, and CooperSurgical Inc are the prominent market players.
The market is forecast to register a CAGR of 6.1% through 2033.
The market is predicted to be worth US$ 570.3 million by 2033.
From 2018 to 2022, the market secured a CAGR of 5.4%.
1. Executive Summary | Uterine Manipulation Devices Market
1.1. Global Market Outlook
1.2. Summary of Statistics
1.3. Key Market Characteristics & Attributes
1.4. Analysis and Recommendations
2. Market Overview
2.1. Market Coverage / Taxonomy
2.2. Market Definition / Scope / Limitations
3. Market Risks and Trends Assessment
3.1. Risk Assessment
3.2. Key Trends Impacting the Market
3.3. Formulation and Product Development Trends
4. Market Background and Foundation Data Points
4.1. Global Market (US$ Million)
4.2. Market Opportunity Assessment (US$ Million)
4.2.1. Total Available Market
4.2.2. Serviceable Addressable Market
4.2.3. Serviceable Obtainable Market
4.3. Market Scenario Forecast
4.3.1. Demand in optimistic Scenario
4.3.2. Demand in Likely Scenario
4.3.3. Demand in Conservative Scenario
4.4. Investment Feasibility Analysis
4.4.1. Investment in Established Markets
4.4.1.1. In Short Term
4.4.1.2. In Long Term
4.4.2. Investment in Emerging Markets
4.4.2.1. In Short Term
4.4.2.2. In Long Term
4.5. Forecast Factors - Relevance & Impact
4.5.1. Top Companies Historical Growth
4.5.2. Global Market Growth
4.5.3. District Cooling Adoption Rate, By Country
4.6. Market Dynamics
4.6.1. Market Driving Factors and Impact Assessment
4.6.2. Prominent Market Challenges and Impact Assessment
4.6.3. Market Opportunities
4.6.4. Prominent Trends in the Global Market & Their Impact Assessment
5. Key Success Factors
5.1. Manufacturers’ Focus on Low Penetration High Growth Markets
5.2. Banking on with Segments High Incremental Opportunity
5.3. Peer Benchmarking
6. Global Market Demand Analysis 2018 to 2022 and Forecast, 2023 to 2033
6.1. Historical Market Analysis, 2018 to 2022
6.2. Current and Future Market Projections, 2023 to 2033
6.3. Y-o-Y Growth Trend Analysis
7. Global Market Value Analysis 2018 to 2022 and Forecast, 2023 to 2033
7.1. Historical Market Value (US$ Million) Analysis, 2018 to 2022
7.2. Current and Future Market Value (US$ Million) Projections, 2023 to 2033
7.2.1. Y-o-Y Growth Trend Analysis
7.2.2. Absolute $ Opportunity Analysis
8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application
8.1. Introduction / Key Findings
8.2. Historical Market Size (US$ Million) Analysis By Application, 2018 to 2022
8.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Application, 2023 to 2033
8.3.1. Total Laparoscopy Hysterectomy (TLH)
8.3.2. Laparoscopic Supracervical Hysterectomy (LSH)
8.3.3. Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
8.3.4. Sacrocolpopexy
8.3.5. Other Applications
8.4. Market Attractiveness Analysis By Application
9. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type
9.1. Introduction / Key Findings
9.2. Historical Market Size (US$ Million) Analysis By Type, 2018 to 2022
9.3. Current and Future Market Size (US$ Million) Analysis and Forecast By Type, 2023 to 2033
9.3.1. Overall
9.3.2. Hospitals
9.3.3. Clinics
9.3.4. Ambulatory Surgery Centers (ASCs)
9.4. Market Attractiveness Analysis By Type
10. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region
10.1. Introduction
10.2. Historical Market Size (US$ Million) Analysis By Region, 2018 to 2022
10.3. Current Market Size (US$ Million) & Analysis and Forecast By Region, 2023 to 2033
10.3.1. North America
10.3.2. Latin America
10.3.3. Europe
10.3.4. Asia Pacific
10.3.5. Middle East and Africa (MEA)
10.4. Market Attractiveness Analysis By Region
11. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
11.1. Introduction
11.2. Pricing Analysis
11.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
11.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
11.4.1. By Country
11.4.1.1. USA
11.4.1.2. Canada
11.4.1.3. Rest of North America
11.4.2. By Application
11.4.3. By Type
11.5. Market Attractiveness Analysis
11.5.1. By Country
11.5.2. By Application
11.5.3. By Type
12. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033
12.1. Introduction
12.2. Pricing Analysis
12.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
12.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
12.4.1. By Country
12.4.1.1. Brazil
12.4.1.2. Mexico
12.4.1.3. Rest of Latin America
12.4.2. By Application
12.4.3. By Type
12.5. Market Attractiveness Analysis
12.5.1. By Country
12.5.2. By Application
12.5.3. By Type
13. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033
13.1. Introduction
13.2. Pricing Analysis
13.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
13.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
13.4.1. By Country
13.4.1.1. Germany
13.4.1.2. France
13.4.1.3. United Kingdom
13.4.1.4. Italy
13.4.1.5. Benelux
13.4.1.6. Nordic Countries
13.4.1.7. Rest of Europe
13.4.2. By Application
13.4.3. By Type
13.5. Market Attractiveness Analysis
13.5.1. By Country
13.5.2. By Application
13.5.3. By Type
14. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033
14.1. Introduction
14.2. Pricing Analysis
14.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
14.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
14.4.1. By Country
14.4.1.1. China
14.4.1.2. Japan
14.4.1.3. South Korea
14.4.1.4. Rest of Asia Pacific
14.4.2. By Application
14.4.3. By Type
14.5. Market Attractiveness Analysis
14.5.1. By Country
14.5.2. By Application
14.5.3. By Type
15. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033
15.1. Introduction
15.2. Pricing Analysis
15.3. Historical Market Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022
15.4. Market Value (US$ Million) & Forecast By Market Taxonomy, 2023 to 2033
15.4.1. By Country
15.4.1.1. GCC Countries
15.4.1.2. South Africa
15.4.1.3. Turkey
15.4.1.4. Rest of Middle East and Africa
15.4.2. By Application
15.4.3. By Type
15.5. Market Attractiveness Analysis
15.5.1. By Country
15.5.2. By Application
15.5.3. By Type
16. Key Countries Market Analysis 2018 to 2022 and Forecast 2023 to 2033
16.1. Introduction
16.1.1. Market Value Proportion Analysis, By Key Countries
16.1.2. Global Vs. Country Growth Comparison
16.2. US Market Analysis
16.2.1. Value Proportion Analysis by Market Taxonomy
16.2.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.2.2.1. By Application
16.2.2.2. By Type
16.3. Canada Market Analysis
16.3.1. Value Proportion Analysis by Market Taxonomy
16.3.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.3.2.1. By Application
16.3.2.2. By Type
16.4. Mexico Market Analysis
16.4.1. Value Proportion Analysis by Market Taxonomy
16.4.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.4.2.1. By Application
16.4.2.2. By Type
16.5. Brazil Market Analysis
16.5.1. Value Proportion Analysis by Market Taxonomy
16.5.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.5.2.1. By Application
16.5.2.2. By Type
16.6. Germany Market Analysis
16.6.1. Value Proportion Analysis by Market Taxonomy
16.6.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.6.2.1. By Application
16.6.2.2. By Type
16.7. France Market Analysis
16.7.1. Value Proportion Analysis by Market Taxonomy
16.7.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.7.2.1. By Application
16.7.2.2. By Type
16.8. Italy Market Analysis
16.8.1. Value Proportion Analysis by Market Taxonomy
16.8.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.8.2.1. By Application
16.8.2.2. By Type
16.9. BENELUX Market Analysis
16.9.1. Value Proportion Analysis by Market Taxonomy
16.9.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.9.2.1. By Application
16.9.2.2. By Type
16.10. UK Market Analysis
16.10.1. Value Proportion Analysis by Market Taxonomy
16.10.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.10.2.1. By Application
16.10.2.2. By Type
16.11. Nordic Countries Market Analysis
16.11.1. Value Proportion Analysis by Market Taxonomy
16.11.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.11.2.1. By Application
16.11.2.2. By Type
16.12. China Market Analysis
16.12.1. Value Proportion Analysis by Market Taxonomy
16.12.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.12.2.1. By Application
16.12.2.2. By Type
16.13. Japan Market Analysis
16.13.1. Value Proportion Analysis by Market Taxonomy
16.13.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.13.2.1. By Application
16.13.2.2. By Type
16.14. South Korea Market Analysis
16.14.1. Value Proportion Analysis by Market Taxonomy
16.14.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.14.2.1. By Application
16.14.2.2. By Type
16.15. GCC Countries Market Analysis
16.15.1. Value Proportion Analysis by Market Taxonomy
16.15.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.15.2.1. By Application
16.15.2.2. By Type
16.16. South Africa Market Analysis
16.16.1. Value Proportion Analysis by Market Taxonomy
16.16.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.16.2.1. By Application
16.16.2.2. By Type
16.17. Turkey Market Analysis
16.17.1. Value Proportion Analysis by Market Taxonomy
16.17.2. Value & Analysis and Forecast by Market Taxonomy, 2018 to 2033
16.17.2.1. By Application
16.17.2.2. By Type
16.17.3. Competition Landscape and Player Concentration in the Country
17. Market Structure Analysis
17.1. Market Analysis by Tier of Companies
17.2. Market Concentration
17.3. Market Share Analysis of Top Players
17.4. Market Presence Analysis
17.4.1. By Regional footprint of Players
17.4.2. Product footprint by Players
18. Competition Analysis
18.1. Competition Dashboard
18.2. Competition Benchmarking
18.3. Competition Deep Dive
18.3.1. Conkin Surgical Instruments Ltd.
18.3.1.1. Overview
18.3.1.2. Product Portfolio
18.3.1.3. Sales Footprint
18.3.1.4. Strategy Overview
18.3.2. Johnson and Johnson
18.3.2.1. Overview
18.3.2.2. Product Portfolio
18.3.2.3. Sales Footprint
18.3.2.4. Strategy Overview
18.3.3. CooperSurgical, Inc.
18.3.3.1. Overview
18.3.3.2. Product Portfolio
18.3.3.3. Sales Footprint
18.3.3.4. Strategy Overview
18.3.4. B. Braun Medical Ltd.
18.3.4.1. Overview
18.3.4.2. Product Portfolio
18.3.4.3. Sales Footprint
18.3.4.4. Strategy Overview
18.3.5. KARL STORZ GmbH & Co. KG
18.3.5.1. Overview
18.3.5.2. Product Portfolio
18.3.5.3. Sales Footprint
18.3.5.4. Strategy Overview
18.3.6. CONMED Corporation
18.3.6.1. Overview
18.3.6.2. Product Portfolio
18.3.6.3. Sales Footprint
18.3.6.4. Strategy Overview
18.3.7. RUDOLF Medical GmbH + Co. KG
18.3.7.1. Overview
18.3.7.2. Product Portfolio
18.3.7.3. Sales Footprint
18.3.7.4. Strategy Overview
18.3.8. LiNA Medical ApS
18.3.8.1. Overview
18.3.8.2. Product Portfolio
18.3.8.3. Sales Footprint
18.3.8.4. Strategy Overview
18.3.9. Richard Wolf GmbH
18.3.9.1. Overview
18.3.9.2. Product Portfolio
18.3.9.3. Sales Footprint
18.3.9.4. Strategy Overview
18.3.10. Utah Medical Products, Inc.
18.3.10.1. Overview
18.3.10.2. Product Portfolio
18.3.10.3. Sales Footprint
18.3.10.4. Strategy Overview
18.3.11. Purple Surgical
18.3.11.1. Overview
18.3.11.2. Product Portfolio
18.3.11.3. Sales Footprint
18.3.11.4. Strategy Overview
18.3.12. Clinical Innovations, LLC
18.3.12.1. Overview
18.3.12.2. Product Portfolio
18.3.12.3. Sales Footprint
18.3.12.4. Strategy Overview
18.3.13. Bissinger Medizintechnik
18.3.13.1. Overview
18.3.13.2. Product Portfolio
18.3.13.3. Sales Footprint
18.3.13.4. Strategy Overview
18.3.14. The O.R. Company (Symmetry Surgical Inc.)
18.3.14.1. Overview
18.3.14.2. Product Portfolio
18.3.14.3. Sales Footprint
18.3.14.4. Strategy Overview
18.3.15. LSI Solutions, Inc.
18.3.15.1. Overview
18.3.15.2. Product Portfolio
18.3.15.3. Sales Footprint
18.3.15.4. Strategy Overview
19. Assumptions and Acronyms Used
20. Research Methodology
Explore Healthcare Insights
View Reports
Uterine Manipulation Devices Market
